Here are five things to know.
1. Mr. Mahjoubi will step into his new role Dec. 30.
2. He will replace Herve Brailly, who is set to become chairman of the company’s advisory board.
3. Mr. Mahjoubi will be paid a base salary of 470,000 euros ($490,000) and also receive free shares in the company, according to the report.
4. Before joining AstraZeneca, Mr. Mahjoubi worked at Roche’s Genentech unit, where he helped lead oncology strategy.
5. The British drugmaker said Mr. Mahjoubi’s successor would be announced shortly, according to the report.
More articles on supply chain:
Amazon looking to develop ‘Uber’ for truck shipments
5 supply chain strategies to control hospital drug spending
FDA removes mental health warning from Pfizer’s anti-smoking drug
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
